Takotsubo syndrome in a patient with atrial fibrillation after electrical cardioversion: a case report

Takotsubo syndrome in a patient with atrial fibrillation after electrical cardioversion: a case report

The paper presents a description of the diagnosis and treatment of takotsubo syndrome in a patient with paroxysmal atrial fibrillation after electrical cardioversion. A case report clearly reflects the need for an integrated diagnostic approach to verify the diagnosis using dynamic echocardiography,...

Full description

Bibliographic Details
Main Authors:	E. S. Sitkova, A. V. Smorgon, R. E. Batalov, A. A. Andreev, S. V. Popov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-12-01
Series:	Российский кардиологический журнал
Subjects:	atrial fibrillation takotsubo syndrome systolic dysfunction electrical cardioversion
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5179

Similar Items

Electrical Cardioversion-Associated Takotsubo Cardiomyopathy: A National Readmission Database 2018 Analysis and Systematic Review
by: Sittinun Thangjui, et al.
Published: (2023-02-01)

Initial Energy for External Electrical Cardioversion of Atrial Fibrillation
by: Edilberto Figueiredo, et al.
Published: (2002-08-01)

Current Status of Internal Cardioversion in Atrial Fibrillation.
by: Andreas Plewan, et al.
Published: (2002-04-01)

Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Paritosh Prasai, et al.
Published: (2023-02-01)

Takotsubo syndrome associated with cardioversion: a systematic review
by: Tayyab Ali Waheed, et al.
Published: (2022-02-01)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
by: Amgad Mentias, et al.
Published: (2021-09-01)

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm
by: Amine El Amrani, et al.
Published: (2021-03-01)

Electrical Cardioversion in Atrial Fibrillation: Success Rates
by: JRMC Admin, et al.
Published: (2018-09-01)

Analysis of clinical risk factors of failed electrical cardioversion in patients with persistent atrial fibrillation or atrial flutter
by: Ki-Hun Kim, et al.
Published: (2023-08-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
by: Samuli Jaakkola, et al.
Published: (2022-12-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

External electrical cardioversion of persistent atrial fibrillation in a patient with a Micra™ Transcatheter Pacing System
by: K. Filipovic, et al.
Published: (2018-01-01)

Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation
by: Konrad Klocek, et al.
Published: (2024-03-01)

Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis
by: Loffredo Lorenzo, et al.
Published: (2012-11-01)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
by: Niklas Höglund, et al.
Published: (2017-04-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial
by: Gregory Y. H. Lip, et al.
Published: (2020-06-01)

The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion
by: Mehrnoush Toufan, et al.
Published: (2017-03-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018-11-01)

Value of transoesophageal echocardiography-guided approach to electrical cardioversion of atrial fibrillation
by: O. S. Kalashnikovа
Published: (2013-06-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion
by: Pysarevska K.О.
Published: (2016-03-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

How to Optimize Cardioversion of Atrial Fibrillation
by: K. E. Juhani Airaksinen
Published: (2022-06-01)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
by: Maciej T. Wybraniec, et al.
Published: (2023-06-01)

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
by: Marco Valerio Mariani, et al.
Published: (2022-10-01)

Atrial fibrillation: real-life experience of a rhythm control with electrical cardioversion in a community hospital
by: Artemiy Okhotin, et al.
Published: (2024-04-01)

Usefulness of risk scores and predictors of atrial fibrillation recurrence after elective electrical cardioversion
by: Daniel Águila‐Gordo, et al.
Published: (2024-01-01)

Anterior-Posterior versus anterior-lateral electrodes position for electrical cardioversion of atrial fibrillation: A meta-analysis of randomized controlled trials
by: Mennaallah Eid, et al.
Published: (2022-12-01)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
by: Ozan Demirel, et al.
Published: (2023-05-01)

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
by: Maciej T. Wybraniec, et al.
Published: (2018-10-01)

Efficacy of Electrical Cardioversion in Relation to Occurrence and Type of Functional Mitral Regurgitation in Patients with Atrial Fibrillation
by: Konrad Klocek, et al.
Published: (2022-04-01)

Upstream Statin Therapy and Long-Term Recurrence of Atrial Fibrillation after Cardioversion: A Propensity-Matched Analysis
by: Lukas Fiedler, et al.
Published: (2021-02-01)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
by: Fabiana Lucà, et al.
Published: (2021-07-01)

Outcome Analysis in Elective Electrical Cardioversion of Atrial Fibrillation Patients: Development and Validation of a Machine Learning Prognostic Model
by: Jean C. Nuñez-Garcia, et al.
Published: (2022-05-01)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
by: Tomas Forslund, et al.
Published: (2021-08-01)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
by: Simon J Walsh, et al.
Published: (2005-10-01)

PPARγ agonist use and recurrence of atrial fibrillation after successful electrical cardioversion
by: Jun Gu, MD, PhD, et al.
Published: (2017-09-01)

CARDIOVERSION WITH BI- AND MONOPHASE DEFIBRILLATORS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
by: V. A. Lusov, et al.
Published: (2010-02-01)